A Phase 2b Efficacy and Safety Study of PTC124 in Subjec

Project: Research project

Project Details

Description

A Phase 2b Efficacy and Safety Study of PTC124 in Subjects with Nonsense-Mutation-Mediated Duchenne and Becker Muscular Dystrophy
StatusFinished
Effective start/end date3/1/082/28/12

Funding

  • PTC Therapeutics, Inc.